Celltrion, Inc. (KRX:068270)
207,500
-5,500 (-2.58%)
Nov 18, 2026, 3:30 PM KST
Celltrion Market Cap
Celltrion has a market cap or net worth of 47.4 trillion as of November 17, 2026. It is the 679th most valuable company in the world and the 9th biggest in South Korea. Its market cap has increased by 14.08% in one year.
Market Cap
47.40T
Enterprise Value
50.15T
Revenue
4.90T
Global Rank
Country Rank
#9 South Korea
PE Ratio
30.34
ChartMarket Cap Chart
Since August 20, 2008, Celltrion's market cap has increased from 103.80B to 47.40T, an increase of 45,563.47%. That is a compound annual growth rate of 39.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 47.40T | 19.69% |
| Dec 30, 2025 | 39.60T | -1.89% |
| Dec 30, 2024 | 40.37T | 44.32% |
| Dec 28, 2023 | 27.97T | 21.61% |
| Dec 29, 2022 | 23.00T | -16.64% |
| Dec 30, 2021 | 27.59T | -43.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 65.38T |
| ALTEOGEN | 12.05T |
| Samsung Epis Holdings | 8.99T |
| SK Biopharmaceuticals | 6.97T |
| HLB Co., Ltd. | 3.76T |
| SK bioscience | 3.11T |
| Hugel | 2.12T |
| ABL Bio | 2.12T |